Table 1 Numbers of subjects (n) studied by noninvasive 1.5 T and 3 T 31P CMRS between 1999 and 2011 and their age (mean ±SD), gender, and clinical assessment at the time of CMRS
1.5 T (n = 124) | 3 T (n = 54) | HCM | DCM | NYHA class I | NYHA class II | NYHA class III | NYHA class IV | |
|---|---|---|---|---|---|---|---|---|
Control | 31 | 14 | ||||||
Age (yr) | 40±8 | 40±18 | ||||||
M/F | 20/11 | 7/7 | ||||||
HF-NICM | 69 | 40 | 23 | 38 | 17 | 56 | 32 | 4 |
Age (yr) | 48±11 | 46±14 | 48±13 | 49±12 | 44±13 | 48±12 | 47±12 | 44±5 |
M/F | 43/26 | 16/26 | 11/12 | 29/9 | 10/7 | 27/29 | 20/12 | 2/2 |
HCM-no HF | 9 | 9 | ||||||
Age (yr) | 59±13 | 59±13 | ||||||
M/F | 5/4 | 4/5 | ||||||
Anterior MI-no HF | 15 | |||||||
Age (yr) | 57±16 | |||||||
M/F | 12/3 |